Edinburgh Research Explorer

The human nuclear exosome targeting complex is loaded onto newly synthesized RNA to direct early ribonucleolysis

Research output: Contribution to journalArticle

  • Michal Lubas
  • Peter Refsing Andersen
  • Aleks Schein
  • Andrzej Dziembowski
  • Grzegorz Kudla
  • Torben Heick Jensen

Related Edinburgh Organisations

Open Access permissions



  • Download as Adobe PDF

    Rights statement: Under a Creative Commons license

    Final published version, 3.22 MB, PDF document

    Licence: Creative Commons: Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND)

Original languageEnglish
Pages (from-to)178-92
Number of pages15
JournalCell Reports
Issue number2
Publication statusPublished - 13 Jan 2015


The RNA exosome complex constitutes the major nuclear eukaryotic 3'-5' exonuclease. Outside of nucleoli, the human nucleoplasmic exosome is directed to some of its substrates by the nuclear exosome targeting (NEXT) complex. How NEXT targets RNA has remained elusive. Using an in vivo crosslinking approach, we report global RNA binding sites of RBM7, a key component of NEXT. RBM7 associates broadly with RNA polymerase II-derived RNA, including pre-mRNA and short-lived exosome substrates such as promoter upstream transcripts (PROMPTs), enhancer RNAs (eRNAs), and 3'-extended products from snRNA and replication-dependent histone genes. Within pre-mRNA, RBM7 accumulates at the 3' ends of introns, and pulse-labeling experiments demonstrate that RBM7/NEXT defines an early exosome-targeting pathway for 3'-extended snoRNAs derived from such introns. We propose that RBM7 is generally loaded onto newly synthesized RNA to accommodate exosome action in case of available unprotected RNA 3' ends.

Download statistics

No data available

ID: 19300879